Pronto disponible para inscripción
This study will open for enrollment soon. Please contact the study team for more information and check back frequently.

ExCrossV - Clinical Trial

¿Cuál es el Propósito de este estudio?

In this study, people will get a new kind of eye transplant.

They'll be randomly chosen (like flipping a coin) to get either a special treated cornea or a regular one.

Doctors will check on them for 2 years after the transplant to see how they're doing and to watch for any side effects.

¿Cuál es la Condición que se está estudiando?

Some people need a corneal transplant because their eye has too many blood vessels.

This study is for those people to help improve their vision and eye health.

¿Quién puede participar en el Estudio?

Who can join this eye study?

- People who need a special kind of eye surgery called high-risk penetrating keratoplasty

- They must not have certain serious eye diseases like Stevens-Johnson syndrome or ocular pemphigoid

- They cannot have eye cancer or uncontrolled high pressure in the eye (glaucoma)

Grupo etario
Adultos

¿Qué Implica?

This study is trying to learn more about a new way to treat eye problems.

Doctors are testing if treating donated corneas before surgery helps people with serious eye issues caused by too many blood vessels.

They also want to understand why some people’s corneas get thin and weak.

This research could help make eye transplants safer and more effective.

Detalles del Estudio

Título Completo
MULTICENTER CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF EX VIVO CORNEAL CROSS-LINKING OF DONOR CORNEAL TISSUE USED FOR VASCULARZIED HIGH-RISK KERATOPLASTY - (ExCrossV)
Investigador Principal
Inmunología ocular
Número de Protocolo
IRB: PRO00117573
NCT: NCT06753916
Fase
Phase Pilot
ClinicalTrials.gov
Estado de inscripción
Pronto disponible para inscripción